Investigation of piwil2 expression as a biomarker in solid tumors of childhood

Main Article Content

Yilmaz Secilmis
Musa Karakukcu
Ozlem Canoz

Abstract

Aim: PIWIL 2 belongs to a subgroup of argonaute proteins, which has an essential role in germ cell development and repair. Recent studies have demonstrated PIWIL 2 as a stem cell marker in some solid tumors. In the present study, we aimed to evaluate the expression of PIWIL 2 in childhood solid tumors and to show being a potential marker for a therapeutic drug.
Materials and Methods: The study included 150 patients who were diagnosed with pediatric solid tumor and followed between 2000 and 2011. Solid tumor preparations were stained with polyclonal PIWIL 2 antibody by using immunohistochemical methods.
Results: Assessment of the tumor sub-groups showed that, among 30 patients with neuroblastoma, there was a strong staining in 5 (16.70%) (p=0.020). PIWIL 2 was showed strong staining in 3 (21.40%) osteosarcoma patients (p=0.030). Among 34 patients with a germ cell tumor, there was a strong staining in 6 (17.60%) patients (p=0.040).
Conclusion: Significant PIWIL 2 positivity was found in neuroblastoma, osteosarcoma and germ cell tumors and it can be a potential marker for these tumors. Because of non-tumor tissue involvement in Wilms’ tumor it can be particularly useful in determining surgical margins.

Downloads

Download data is not yet available.

Article Details

How to Cite
Secilmis, Y., Karakukcu, M., & Canoz, O. (2021). Investigation of piwil2 expression as a biomarker in solid tumors of childhood. Annals of Medical Research, 28(8), 1525–1531. Retrieved from http://annalsmedres.org/index.php/aomr/article/view/3880
Section
Original Articles

Most read articles by the same author(s)